CD8A and neoplasm: To investigate the role of CD8+ cells in EGCG-mediated tumor inhibition, we depleted the CD8+ cell population using an anti-CD8 depleting antibody in C57BL/6 mice undergoing B16F10 implantation and EGCG treatment.